Bianca M. L. Stelten

Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start

Bianca M. L. Stelten, Hidde H. Huidekoper, Bart P.C. van de Warrenburg et al. · Neurology · 2018 · 130 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study

Bianca M. L. Stelten, Maria Teresa Dotti, Aad Verrips et al. · Orphanet Journal of Rare Diseases · 2021 · 62 citations · Full text

Medicine, Internal Medicine, Neurology +13

The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies

Aad Verrips, Maria Teresa Dotti, Andrea Mignarri et al. · Neurological Sciences · 2019 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Cerebrotendinous xanthomatosis without neurological involvement

Bianca M. L. Stelten, Frederick J. Raal, A. David Marais et al. · Journal of Internal Medicine · 2021 · 35 citations · Full text

Life Sciences, Genetics, Neurology +14

Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis

Bianca M. L. Stelten, Olivier Bonnot, Hidde H. Huidekoper et al. · Journal of Inherited Metabolic Disease · 2017 · 33 citations

Medicine, Neurology, Pathology +7